ARID1A protein expression in endometriosis-associated ovarian carcinomas
article
OA: diamond
CC0
Abstract
Abstract Epithelial ovarian carcinoma is leading cause of death among gynaecologic malignancies. Somatic mutation of ARID1A gene often observed in endometriosis-associated ovarian carcinoma cases. This mutation causes loss of ARID1A protein expression on tumor-bearing tissues. This study aims to investigate ARID1A protein expression in endometriosis-associated ovarian carcinoma cases in Indonesia. The archive of Formalin-fixed paraffin embedded (FFPE) tissue of 11 endometrial carcinomas (EC), 16 clear cell carcinoma (CCC), and 23 serous carcinomas (SC) from January 1, 2016, to December 31, 2017. The ARID1A expression were analyzed by using Kolmogorov Smirnov and Fisher’s Exact Tests. Majority of patients were older than 50 years (90%). Loss of ARID1A expression in tumor tissue was significantly low in the SC group (8.7%) compared to the EC group (27.3%) and the CCC group (62.5%) (p = 0.021). This study showed that ARID1A expression, was not associated with FIGO stage (p = 0,423), and with histological grade of the cases in EC group (p = 0,544) and SC group (p = 0,395). Loss of ARID1A expression was more frequently found in EC and CCC cases. Loss of ARID1A expression was not associated with FIGO stage and histological grade.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- BAF250a Expression in Atypical Endometriosis and Endometriosis-Associated Ovarian Cancer via openalex
- Expression is Down-Regulated by Oxidative Stress in Endometriosis and Endometriosis-Associated Ovarian Cancer via openalex
- <i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas via openalex
- Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation? via openalex
- Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review). via openalex
- Molecular Pathogenesis of Ovarian Clear Cell Carcinoma via openalex
- Pathogenesis and the Role of ARID1A Mutation in Endometriosis-related Ovarian Neoplasms via openalex
- W2068275655 via openalex
- W2070369494 via openalex
- W2075053675 via openalex
- W2090287261 via openalex
- W2092324058 via openalex
- W2124652061 via openalex
- W2125681453 via openalex
- W2134576998 via openalex
- W2174510671 via openalex
- W2305551225 via openalex
- W2326227281 via openalex
- W2552862252 via openalex
- W2561717201 via openalex
- W1525668142 via openalex
- W2765547972 via openalex
- W1704024882 via openalex
- W1974756790 via openalex
- W1975141727 via openalex
- W2013991443 via openalex
- W2040588648 via openalex
- W2045777875 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK